Uterine papillary serous cancer

  • David G Allen University of Melbourne
Keywords: uterine papillary serous cancer, treatment


There is much about the management of endometrial cancer that remains controversial. The literature contains very little good evidence to guide our practice on uterine papillary serous cancer (UPSC). UPSC is an aggressive histological subtype of endometrial cancer, accounting for less than 5% of its incidence, but 40% of its mortality. UPSC has a higher propensity for lymphovascular space invasion (LVSI), and intraperitoneal as well as extra-abdominal spread, than the more common endometrioid cancers.

Author Biography

David G Allen, University of Melbourne
MBChB, MMed(O&G), PhD, FCOG(SA), AFRACMA, FRANZCOG, CGO Gynaecological Oncologist Mercy Hospital for Women Melbourne Australia
Guest Editorial